North America Microfluidics Market Size & Outlook
North America microfluidics market, 2018-2030 (US$M)
Related Markets
North America microfluidics market highlights
- The North America microfluidics market generated a revenue of USD 13,723.2 million in 2023.
- The market is expected to grow at a CAGR of 10.6% from 2024 to 2030.
- In terms of segment, medical was the largest revenue generating technology in 2023.
- Medical is the most lucrative technology segment registering the fastest growth during the forecast period.
- Country-wise, Canada is expected to register the highest CAGR from 2024 to 2030.
North America data book summary
| Market revenue in 2023 | USD 13,723.2 million |
| Market revenue in 2030 | USD 27,852.9 million |
| Growth rate | 10.6% (CAGR from 2023 to 2030) |
| Largest segment | Medical |
| Fastest growing segment | Medical |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Medical, Non-Medical |
| Key market players worldwide | Illumina Inc, Roche Holding AG ADR, PerkinElmer, Agilent Technologies Inc, Bio-Rad Laboratories Inc, Danaher Corp, Abbott Laboratories, Thermo Fisher Scientific Inc, Standard BioTools Inc |
Other key industry trends
- In terms of revenue, North America region accounted for 42.7% of the global microfluidics market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 18,147.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Microfluidics Market Scope
Microfluidics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
North America microfluidics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to microfluidics market will help companies and investors design strategic landscapes.
Medical was the largest segment with a revenue share of 83.98% in 2023. Horizon Databook has segmented the North America microfluidics market based on medical, non-medical covering the revenue growth of each sub-segment from 2018 to 2030.
North America accounted for the largest revenue share in 2021. An increase in research funding from government organizations and industries is the major factor driving the market growth. The demand for microfluidics devices in the research and diagnostics field has spurred industry-academia collaboration to accelerate the commercialization of lab-built devices. For instance, in July 2020, Fluidigm Corporation executed a letter contract with the National Institute of Biomedical Imaging and Bioengineering and the National Institutes of Health for the Rapid Acceleration of Diagnostics program. This funding was expected to bring the benefit of advanced micro- and nanotechnology to patients globally.
Reasons to subscribe to North America microfluidics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America microfluidics market databook
-
Our clientele includes a mix of microfluidics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America microfluidics market , including forecasts for subscribers. This continent databook contains high-level insights into North America microfluidics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
North America microfluidics market size, by country, 2018-2030 (US$M)
North America Microfluidics Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
